Jing Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jing Li has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Michael Maes
Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
7 shared publications - Abbas Firras Almuala
International NIMETOX Center, Sichuan Provincial Center for Mental Health, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China
3 shared publications - Yingqian Zhang
University of Electronic Science and Technology of China
3 shared publications - Apichat Suratanee
Department of Mathematics, Faculty of Applied Science, King Mongkut’s University of Technology North Bangkok, Bangkok 10800, Thailand
2 shared publications Jiajun Jiang
School of Psychiatry, North Sichuan Medical College, Nanchong, 637000, People’s Republic of China
2 shared publicationsKaiqi Gu
Department of Psychiatry, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
2 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 18, 1-12
Cyclic Alternating Pattern and Sleep Microstructure in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Objective: To systematically review polysomnographic sleep differences, with emphasis on cyclic alternating pattern (CAP) microstructure, between patients with Parkinson’s disease (PD) and healthy controls (HC). Methods: We searched MEDLINE (via OVID), EMBASE (via OVID), CINAHL (via EBSCOhost), APA PsycArticles (via EBSCOhost), and Evidence-Based Medicine databases (via EBSCOhost) for studies published from January 1, 2020, to September 15, 2025. Eligible studies enrolled adults with idiopathic PD, included an internal HC group, used overnight polysomnography, and reported extractable CAP-related outcomes. Study quality was assessed with the Newcastle-Ottawa Scale. Random-effects meta-analyses were performed using Hedges’ g with restricted maximum-likelihood estimation, and certainty of evidence was appraised with GRADE. Results: Four studies were included. PD patients showed significant reductions in CAP rate, CAP sequence duration, and CAP index (all p< 0.05), with low statistical heterogeneity. Macrostructural parameters showed no statistically significant pooled differences, and several had moderate-to-high heterogeneity. GRADE certainty was very low because the evidence came from a small number of observational studies. Conclusion: Within a limited evidence base, CAP-related microstructure shows a consistent pattern of reduction in clinically diagnosed PD, whereas macrostructural alterations were not stable across the included studies. CAP measures may provide complementary information in future PD sleep research, but the present evidence is insufficient to support their use as validated biomarkers.
- 1 June 2026
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 18, 1-12
Open AccessCyclic Alternating Pattern and Sleep Microstructure in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Objective: To systematically review polysomnographic sleep differences, with emphasis on cyclic alternating pattern (CAP) microstructure, between patients with Parkinson’s disease (PD) and healthy controls (HC). Methods: We searched MEDLINE (via OVID), EMBASE (via OVID), CINAHL (via EBSCOhost), APA PsycArticles (via EBSCOhost), and Evidence-Based Medicine databases (via EBSCOhost) for studies published from January 1, 2020, to September 15, 2025. Eligible studies enrolled adults with idiopathic PD, included an internal HC group, used overnight polysomnography, and reported extractable CAP-related outcomes. Study quality was assessed with the Newcastle-Ottawa Scale. Random-effects meta-analyses were performed using Hedges’ g with restricted maximum-likelihood estimation, and certainty of evidence was appraised with GRADE. Results: Four studies were included. PD patients showed significant reductions in CAP rate, CAP sequence duration, and CAP index (all p< 0.05), with low statistical heterogeneity. Macrostructural parameters showed no statistically significant pooled differences, and several had moderate-to-high heterogeneity. GRADE certainty was very low because the evidence came from a small number of observational studies. Conclusion: Within a limited evidence base, CAP-related microstructure shows a consistent pattern of reduction in clinically diagnosed PD, whereas macrostructural alterations were not stable across the included studies. CAP measures may provide complementary information in future PD sleep research, but the present evidence is insufficient to support their use as validated biomarkers.
- 22 April 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 408, 121840
Neurocognitive deficits, psychotrauma, and inflammation shape major depressive disorder and its phenome features
- 22 April 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 408, 121840
Neurocognitive deficits, psychotrauma, and inflammation shape major depressive disorder and its phenome features
- Open Access
- 1 March 2026
- Published by Taylor & Francis in Psychology Research and Behavior Management
- Vol. ume 19, 1-23
Adolescent Insomnia Disorder – Problematic Internet Use Nexus: A Convergent Developmental Trajectory – Bridging Neuroimaging Biomarkers, Molecular Susceptibility, and Environmental-Neurocognitive Cascades
Adolescent Insomnia Disorder (ID) and Problematic Internet Use (PIU) represent a pressing global public health challenge, frequently co-occurring and synergistically impacting mental and physical well-being. Despite their high comorbidity, a comprehensive integrative model elucidating their shared pathophysiology is lacking. This review is the first to propose a Convergent Developmental Trajectory Model, which posits that ID and PIU in adolescents are sustained by a self-reinforcing cycle driven by the dynamic interplay of three core components: (a) a shared biological vulnerability stemming from adolescent-specific neurodevelopment and molecular genetics; (b) common environmental triggers, such as academic stress and adverse childhood experiences; and (c) neurocognitive reinforcement through impaired inhibitory control and dysregulated reward processing. We synthesize converging evidence from neuroimaging, molecular studies, and environmental psychology to demonstrate how these components interact within the adolescent developmental context to perpetuate a vicious cycle. The model underscores that effective interventions must target these shared pathways, for instance, by developing transdiagnostic Cognitive Behavioral Therapy (CBT) protocols specifically designed for ID-PIU comorbidity. Future research should prioritize longitudinal neurodevelopmental studies and multi-omics profiling to enable early risk stratification and personalized approaches. Addressing this complex issue requires interdisciplinary collaboration to formulate precision therapies and evidence-based public health policies.
- 1 March 2026
- Published by Taylor & Francis in Psychology Research and Behavior Management
- Vol. ume 19, 1-23
Open AccessAdolescent Insomnia Disorder – Problematic Internet Use Nexus: A Convergent Developmental Trajectory – Bridging Neuroimaging Biomarkers, Molecular Susceptibility, and Environmental-Neurocognitive Cascades
Adolescent Insomnia Disorder (ID) and Problematic Internet Use (PIU) represent a pressing global public health challenge, frequently co-occurring and synergistically impacting mental and physical well-being. Despite their high comorbidity, a comprehensive integrative model elucidating their shared pathophysiology is lacking. This review is the first to propose a Convergent Developmental Trajectory Model, which posits that ID and PIU in adolescents are sustained by a self-reinforcing cycle driven by the dynamic interplay of three core components: (a) a shared biological vulnerability stemming from adolescent-specific neurodevelopment and molecular genetics; (b) common environmental triggers, such as academic stress and adverse childhood experiences; and (c) neurocognitive reinforcement through impaired inhibitory control and dysregulated reward processing. We synthesize converging evidence from neuroimaging, molecular studies, and environmental psychology to demonstrate how these components interact within the adolescent developmental context to perpetuate a vicious cycle. The model underscores that effective interventions must target these shared pathways, for instance, by developing transdiagnostic Cognitive Behavioral Therapy (CBT) protocols specifically designed for ID-PIU comorbidity. Future research should prioritize longitudinal neurodevelopmental studies and multi-omics profiling to enable early risk stratification and personalized approaches. Addressing this complex issue requires interdisciplinary collaboration to formulate precision therapies and evidence-based public health policies.
- Open Access
- 16 February 2025
- Published by Elsevier in Journal of Advanced Research
- Vol. 78, 543-553
Autoimmune responses to myelin-associated proteins as diagnostic and prognostic biomarkers of relapsing-remitting multiple sclerosis: Associations with human herpesvirus-6 and Epstein-Barr virus reactivation
- 16 February 2025
- Published by Elsevier in Journal of Advanced Research
- Vol. 78, 543-553
Open AccessAutoimmune responses to myelin-associated proteins as diagnostic and prognostic biomarkers of relapsing-remitting multiple sclerosis: Associations with human herpesvirus-6 and Epstein-Barr virus reactivation
- Open Access
Immune Cell Exhaustion and Apoptotic Markers in Major Depressive Disorder: Effects of in Vitro Cannabidiol Administration
Background: Immune dysregulation is a component of Major Depressive Disorder (MDD). Cannabidiol (CBD) has immunomodulatory and putative antidepressant effects. The relationship between apoptotic and exhaustion immune markers and the clinical features of MDD and the effects of CBD on these markers are still unknown. Objectives: To assess pro-apoptotic (CD95) and T cell exhaustion (TIM-3) markers on immune cells in patients with MDD, as well as the impact of in vitro CBD administration on these markers. Methods: We recruited healthy controls and MDD patients and evaluated the immunophenotypes of T/B lymphocytes using flow cytometry in unstimulated and anti-CD3/CD28 stimulated conditions. We evaluated the immune profiles of M1 macrophages, T helper (Th)17 cells, immune-inflammatory response system (IRS), T cell proliferation, and immune-related neurotoxicity (IRN). We investigated the in vitro effects of CBD on immune cell subsets at concentrations of 0.1 µg/mL, 1 µg/mL, and 10.0 µg/mL. Results: The stimulated CD3+CD95+ cell percentages were substantially correlated with the number of depressive episodes, recurrence of illness, and suicidal behaviors. The stimulated CD8+TIM-3+ cell percentages were substantially and inversely associated with the M1, IRS, CIRS, T cell growth, and IRN immune profiles. TIM-3+ bearing CD3+, CD4+ and CD8+,cells were significantly suppressed by lower CBD concentrations (0.1 – 1 µg/mL). TIM-3+ and all CD95+ bearing cells, with the exception of CD3+CD95+, were suppressed by the higher CBD concentrations. Discussion: Aberrations in immune checkpoint molecular processes impact the features of MDD. CBD significantly impacts apoptotic and exhaustion processes thereby possibly interfering with immune homeostasis.
Open AccessImmune Cell Exhaustion and Apoptotic Markers in Major Depressive Disorder: Effects of in Vitro Cannabidiol Administration
Background: Immune dysregulation is a component of Major Depressive Disorder (MDD). Cannabidiol (CBD) has immunomodulatory and putative antidepressant effects. The relationship between apoptotic and exhaustion immune markers and the clinical features of MDD and the effects of CBD on these markers are still unknown. Objectives: To assess pro-apoptotic (CD95) and T cell exhaustion (TIM-3) markers on immune cells in patients with MDD, as well as the impact of in vitro CBD administration on these markers. Methods: We recruited healthy controls and MDD patients and evaluated the immunophenotypes of T/B lymphocytes using flow cytometry in unstimulated and anti-CD3/CD28 stimulated conditions. We evaluated the immune profiles of M1 macrophages, T helper (Th)17 cells, immune-inflammatory response system (IRS), T cell proliferation, and immune-related neurotoxicity (IRN). We investigated the in vitro effects of CBD on immune cell subsets at concentrations of 0.1 µg/mL, 1 µg/mL, and 10.0 µg/mL. Results: The stimulated CD3+CD95+ cell percentages were substantially correlated with the number of depressive episodes, recurrence of illness, and suicidal behaviors. The stimulated CD8+TIM-3+ cell percentages were substantially and inversely associated with the M1, IRS, CIRS, T cell growth, and IRN immune profiles. TIM-3+ bearing CD3+, CD4+ and CD8+,cells were significantly suppressed by lower CBD concentrations (0.1 – 1 µg/mL). TIM-3+ and all CD95+ bearing cells, with the exception of CD3+CD95+, were suppressed by the higher CBD concentrations. Discussion: Aberrations in immune checkpoint molecular processes impact the features of MDD. CBD significantly impacts apoptotic and exhaustion processes thereby possibly interfering with immune homeostasis.
- Open Access
Do viral-associated pathways underlie the immune activation during the acute phase of severe major depression?
Background: Major depressive disorder (MDD) and its most severe phenotype, major dysmood disorder (MDMD), are distinguished by the activation of the immune-inflammatory response system, T cell activation, and a relative T regulatory cell suppression. Nevertheless, these immune data were not used to characterize the features of the immune protein-protein interaction (PPI) network of MDMD. Objectives: To identify the network’s nodes and bottlenecks as well as the biological processes that are overrepresented in the PPI network, we conducted PPI network, annotation, and enrichment analyses. Results: The PPI network analysis has identified the following backbone genes: tumor necrosis factor-α (TNF), interleukin (IL)6, CXCL12, CXCL10, CCL5, cluster of differentiation (CD)4, CD8A, human leukocyte antigen (HLA)-DR, and FOXP3. A “cellular and defense response”, an “immune response system response”, and “a viral process that involves viral protein interaction with cytokines and cytokine receptors” were all highly associated with the network. The chemokine network and TNF and nuclear factor-κB (NFKB) pathways are additional biological pathways that are enriched in the PPI network. Molecular complex detection extracted one component from the data, including viral protein interaction with cytokine and cytokine receptors and “regulated by RELA” (an NFKB subunit). Conclusions: Viral processes may underlie the activation of T cells and the cytokine and chemokine networks that are associated with MDMD. Future research on the pathogenesis of MDMD and MDD should examine whether and which viral infections are associated with the onset of these conditions, or whether viral reactivation is associated with the recurrence of illness.
Open AccessDo viral-associated pathways underlie the immune activation during the acute phase of severe major depression?
Background: Major depressive disorder (MDD) and its most severe phenotype, major dysmood disorder (MDMD), are distinguished by the activation of the immune-inflammatory response system, T cell activation, and a relative T regulatory cell suppression. Nevertheless, these immune data were not used to characterize the features of the immune protein-protein interaction (PPI) network of MDMD. Objectives: To identify the network’s nodes and bottlenecks as well as the biological processes that are overrepresented in the PPI network, we conducted PPI network, annotation, and enrichment analyses. Results: The PPI network analysis has identified the following backbone genes: tumor necrosis factor-α (TNF), interleukin (IL)6, CXCL12, CXCL10, CCL5, cluster of differentiation (CD)4, CD8A, human leukocyte antigen (HLA)-DR, and FOXP3. A “cellular and defense response”, an “immune response system response”, and “a viral process that involves viral protein interaction with cytokines and cytokine receptors” were all highly associated with the network. The chemokine network and TNF and nuclear factor-κB (NFKB) pathways are additional biological pathways that are enriched in the PPI network. Molecular complex detection extracted one component from the data, including viral protein interaction with cytokine and cytokine receptors and “regulated by RELA” (an NFKB subunit). Conclusions: Viral processes may underlie the activation of T cells and the cytokine and chemokine networks that are associated with MDMD. Future research on the pathogenesis of MDMD and MDD should examine whether and which viral infections are associated with the onset of these conditions, or whether viral reactivation is associated with the recurrence of illness.
- Open Access
- 1 August 2024
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 20, 1513-1522
Abnormal Serum BDNF and p-mTOR in MDD in Adolescents with Childhood Trauma
Background: Adolescents with major depressive (MDD) episodes associated with childhood trauma have a poorer response to treatment and a higher risk of suicide. The underlying etiology is unclear. Brain-derived neurotrophic factor (BDNF) could improve depressive symptoms by down-regulating mammalian target of rapamycin (mTOR) signaling pathways, which was involved in adverse environmental stimuli during neurodevelopment. BDNF and mTOR have not been reported simultaneously in adolescents with major depressive episodes associated with childhood trauma. Methods: Childhood Trauma Questionnaire-Short Form (CTQ-SF), Children’s Depression Inventory (CDI) and Children’s Depression Rating Scale-Revised (CDRS-R) were used to evaluate the recruited adolescents with major depression episodes. Serum BDNF and p-mTOR levels were measured by ELISA in 31 adolescents with major depression episodes with childhood trauma and 18 matched healthy control. Results: The serum levels of BDNF were significantly lower (p< 0.001); and the serum levels of p-mTOR were high (p=0.003) in the adolescents with the first episode of major depressive episode accompanied by childhood trauma. Of the 31 adolescents with major depressive episodes, 17 had suicide or self-injury. Compared with the healthy control group, the serum levels of BDNF in patients with suicide or self-injury were lower than those without suicide or self-injury(p< 0.001); the serum levels of p-mTOR were higher than those without suicide or self-injury (p=0.01). While in patients without suicide or self-injury, only serum p-mTOR was significantly higher than that in healthy group (p=0.028). BDNF was negatively correlated with CDRS-R (r=− 0.427, p=0.006), p-mTOR was positively correlated with CDI (r=0.364, p=0.048). According to Receiver Operating Characteristic Curve (ROC), the combination of serum BDNF and p-mTOR levels have better diagnostic value. Conclusion: Neurotrophic and signaling pathways, involving BDNF and p-mTOR, may play a role in adolescent MDD with a history of childhood trauma, especially patients with suicide and self-injury tendencies.
- 1 August 2024
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 20, 1513-1522
Open AccessAbnormal Serum BDNF and p-mTOR in MDD in Adolescents with Childhood Trauma
Background: Adolescents with major depressive (MDD) episodes associated with childhood trauma have a poorer response to treatment and a higher risk of suicide. The underlying etiology is unclear. Brain-derived neurotrophic factor (BDNF) could improve depressive symptoms by down-regulating mammalian target of rapamycin (mTOR) signaling pathways, which was involved in adverse environmental stimuli during neurodevelopment. BDNF and mTOR have not been reported simultaneously in adolescents with major depressive episodes associated with childhood trauma. Methods: Childhood Trauma Questionnaire-Short Form (CTQ-SF), Children’s Depression Inventory (CDI) and Children’s Depression Rating Scale-Revised (CDRS-R) were used to evaluate the recruited adolescents with major depression episodes. Serum BDNF and p-mTOR levels were measured by ELISA in 31 adolescents with major depression episodes with childhood trauma and 18 matched healthy control. Results: The serum levels of BDNF were significantly lower (p< 0.001); and the serum levels of p-mTOR were high (p=0.003) in the adolescents with the first episode of major depressive episode accompanied by childhood trauma. Of the 31 adolescents with major depressive episodes, 17 had suicide or self-injury. Compared with the healthy control group, the serum levels of BDNF in patients with suicide or self-injury were lower than those without suicide or self-injury(p< 0.001); the serum levels of p-mTOR were higher than those without suicide or self-injury (p=0.01). While in patients without suicide or self-injury, only serum p-mTOR was significantly higher than that in healthy group (p=0.028). BDNF was negatively correlated with CDRS-R (r=− 0.427, p=0.006), p-mTOR was positively correlated with CDI (r=0.364, p=0.048). According to Receiver Operating Characteristic Curve (ROC), the combination of serum BDNF and p-mTOR levels have better diagnostic value. Conclusion: Neurotrophic and signaling pathways, involving BDNF and p-mTOR, may play a role in adolescent MDD with a history of childhood trauma, especially patients with suicide and self-injury tendencies.
- Open Access
- 27 June 2024
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1422511
Relationship between serum inflammatory cytokines and suicide risk in patients with major depressive disorder
Background: Studies have shown that increased inflammatory cytokines are associated with suicide risk, but the relationship between suicide risk and inflammatory cytokines is not clear. This study aimed to investigate the relationship between specific inflammatory markers and suicide risk in patients with MDD.Methods: This is a cross-sectional study. Firstly, we measured and compared psychological characteristics and 10 peripheral inflammatory cytokines in 130 MDD patients and 130 healthy controls(HC). Secondly, MDD patients were divided into 4 groups according to the severity of suicide risk for comparison between groups. Finally, multiple linear regression analysis was used to explore the predictors of suicide risk.Results: We found that the group with higher suicide risk had higher levels of IL-6, CRP, TNF-α, CXCL-2, and IFN-γ, and lower levels of IL-2 and IL-8 (all p<0.01). However, we found no difference in CRP between MIS and LS groups (p=0.337). Regression models were well-fitted. IL-2,IL-8 negatively predicted suicide risk (all p<0.05),IL-6,CRP,TNF-α,CXCL-2, and IFN-γ can positively predict the risk of suicide (all p<0.05).Limitations: This study employed a self-assessment scale.Conclusions: The higher the levels of IL-6, CRP, TNF-α, CXCL-2, and IFN-γ and the lower the levels of IL-2 and IL-8 of MDD patients, the higher the risk of suicide.
- 27 June 2024
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1422511
Open AccessRelationship between serum inflammatory cytokines and suicide risk in patients with major depressive disorder
Background: Studies have shown that increased inflammatory cytokines are associated with suicide risk, but the relationship between suicide risk and inflammatory cytokines is not clear. This study aimed to investigate the relationship between specific inflammatory markers and suicide risk in patients with MDD.Methods: This is a cross-sectional study. Firstly, we measured and compared psychological characteristics and 10 peripheral inflammatory cytokines in 130 MDD patients and 130 healthy controls(HC). Secondly, MDD patients were divided into 4 groups according to the severity of suicide risk for comparison between groups. Finally, multiple linear regression analysis was used to explore the predictors of suicide risk.Results: We found that the group with higher suicide risk had higher levels of IL-6, CRP, TNF-α, CXCL-2, and IFN-γ, and lower levels of IL-2 and IL-8 (all p<0.01). However, we found no difference in CRP between MIS and LS groups (p=0.337). Regression models were well-fitted. IL-2,IL-8 negatively predicted suicide risk (all p<0.05),IL-6,CRP,TNF-α,CXCL-2, and IFN-γ can positively predict the risk of suicide (all p<0.05).Limitations: This study employed a self-assessment scale.Conclusions: The higher the levels of IL-6, CRP, TNF-α, CXCL-2, and IFN-γ and the lower the levels of IL-2 and IL-8 of MDD patients, the higher the risk of suicide.